Cargando…
Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients
At present, immunotherapy is widely used for different mismatch repair (dMMR) or highly microsatellite instability (MSI-H) colorectal cancer patients, and tumor mutation burden (TMB) is a valuable independent predictor of response to immunotherapy. However, specific gene mutations and their relation...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034916/ https://www.ncbi.nlm.nih.gov/pubmed/33714943 http://dx.doi.org/10.18632/aging.202756 |